Top 25 Companies in Global Motion Sickness Treatment Market (2025–2035): Expert View by Spherical Insights
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The global motion sickness treatment market refers to the industry focused on medications, devices, and therapies used to prevent and manage symptoms such as nausea, vomiting, and dizziness caused by motion during travel. These treatments are developed using key raw materials including active pharmaceutical ingredients such as antihistamines and anticholinergics (e.g., scopolamine), along with excipients, transdermal patch materials, and wearable device components. The treatments are widely used across applications such as air, sea, and road travel, military operations, and space missions, as well as for general consumer use in preventing travel-related discomfort. The market is witnessing key trends including growing preference for over-the-counter medications, development of non-drowsy formulations, wearable therapeutic devices, and personalized treatment options, creating significant growth opportunities. Additionally, government initiatives such as regulatory approvals, safety standards, and healthcare awareness programs are supporting innovation and accessibility, ensuring effective treatment availability and sustained global market expansion.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Motion Sickness Treatment Market.
Market Segmentation
Global Motion Sickness Treatment Market Size, Share, By Treatment Type (Anticholinergics, First-Generation Antihistamines, and More), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and More), By Dosage Form (Oral Tablets/Chews, and More), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Motion Sickness Treatment Market Size & Statistics
- The Market Size for Motion Sickness Treatment Was estimated to be worth USD 638.26 Million in 2024.
- The Market is going to Expand at a CAGR of 3.09% between 2025 and 2035.
- The Motion Sickness Treatment Market Size is anticipated to reach USD 892.27 Million by 2035.
- North America is expected to generate the highest demand during the forecast period in the Motion Sickness Treatment Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Motion Sickness Treatment Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Motion Sickness Treatment market. Asia Pacific growth is driven by expanding healthcare infrastructure, increasing travel and tourism, rising disposable income, growing awareness of motion sickness treatments, expanding healthcare access, and strong government initiatives supporting pharmaceutical development and distribution.
North America is expected to generate the highest demand during the forecast period in the Motion Sickness Treatment market. North America leads due to high prevalence of travel and motion-related activities, advanced healthcare infrastructure, strong pharmaceutical presence, widespread awareness of motion sickness treatments, and supportive government regulations for drug approval and safety.
Ready to lead the Motion Sickness Treatment Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Motion Sickness Treatment Market
- Non‑drowsy medication formulations
- Increasing OTC treatment availability
- Growth in wearable anti‑motion devices
- Personalized therapeutic solutions
- Natural and herbal remedies
- Combination therapy products
- Digital health integration (apps & monitoring)
- Pediatric‑specific formulations
- Travel and tourism‑driven demand
- Enhanced safety and efficacy clinical research
- Non‑drowsy Medication Formulations
Pharmaceutical companies are developing motion sickness drugs that minimize sedation, allowing patients to remain alert while traveling, increasing convenience and adoption, especially among professionals, travelers, and frequent commuters.
- Increasing OTC Treatment Availability
Over-the-counter (OTC) motion sickness medications are becoming more accessible, enabling consumers to self-treat without prescriptions, driving market growth through convenience, affordability, and awareness of preventive care for travel-related motion sickness.
- Growth in Wearable Anti‑Motion Devices
Wearable devices, such as acupressure wristbands or motion-sensing gadgets, provide non-pharmacological relief, offering real-time motion stabilization or therapeutic stimulation, attracting consumers seeking drug-free and side-effect-free options.
- Personalized Therapeutic Solutions
Tailored treatment plans based on individual susceptibility, medical history, or travel patterns are emerging, enhancing efficacy and patient adherence while enabling healthcare providers to optimize therapy outcomes.
- Natural and Herbal Remedies
Rising preference for plant-based and herbal interventions, including ginger and peppermint extracts, is driving market expansion due to their perceived safety, minimal side effects, and compatibility with holistic wellness trends.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Motion Sickness Treatment market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Motion Sickness Treatment Market.
Top 25 Companies Leading the Motion Sickness Treatment Market
- GlaxoSmithKline plc
- Pfizer Inc.
- Johnson & Johnson
- Prestige Consumer Healthcare Inc.
- Perrigo Company plc
- Sanofi S.A.
- Novartis AG
- Baxter International Inc.
- Abbott Laboratories
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Bausch + Lomb Corp.
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Lupin Ltd.
- Myungmoon Pharm Co., Ltd.
- Wellspring Pharmaceutical Corp.
- Caleb Pharmaceuticals Inc.
- DM Pharma
- Yunnan Baiyao Group Co., Ltd.
- Reliefband Technologies LLC
- Astellas Pharma Inc.
- Amneal Pharmaceuticals LLC
- Cipla Ltd.
- Taiyo Pharmaceutical Co., Ltd.
- GlaxoSmithKline plc
Headquarters: Brentford, United Kingdom.
Revenue (2025): approx. USD 40+ billion.
GlaxoSmithKline is a global healthcare leader offering motion sickness treatments such as antihistamines and antiemetics. Its strong R&D capabilities and extensive global presence support broad access and continuous innovation in travel‑related therapies.
- Pfizer Inc.
Headquarters: New York, USA.
Revenue (2025): approx. USD 58+ billion.
Pfizer develops and markets prescription and OTC motion sickness medications. With robust clinical research and global distribution, it enhances treatment accessibility and efficacy worldwide.
- Johnson & Johnson
Headquarters: New Brunswick, New Jersey, USA.
Revenue (2025): approx. USD 95+ billion.
Johnson & Johnson offers consumer and OTC solutions addressing motion sickness symptoms. Its strong brand portfolio and global reach drive market leadership.
- Prestige Consumer Healthcare Inc.
Headquarters: Tarrytown, New York, USA.
Revenue (2025): approx. USD 1.5+ billion.
Prestige Consumer Healthcare markets popular OTC remedies for motion sickness. Focused on consumer‑oriented product innovation and brand strength, it meets growing travel wellness demand.
- Perrigo Company plc
Headquarters: Dublin, Ireland.
Revenue (2025): approx. USD 5+ billion.
Perrigo manufactures OTC motion sickness treatments under global private‑label and branded portfolios. It’s manufacturing scale and retail partnerships support wide market distribution and accessibility.
Are you ready to discover more about the Motion Sickness Treatment market?
The report provides an in-depth analysis of the leading companies operating in the Motion Sickness Treatment market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Motion Sickness Treatment Market.
Company Profile
- GlaxoSmithKline plc
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Pfizer Inc.
- Johnson & Johnson
- Prestige Consumer Healthcare Inc.
- Perrigo Company plc
- Sanofi S.A.
- Novartis AG
- Baxter International Inc.
- Abbott Laboratories
- Others.
Conclusion
The Global Motion Sickness Treatment Market is witnessing steady growth, driven by increasing travel, rising prevalence of motion sickness, and growing awareness of preventive therapies. Treatments utilize active pharmaceutical ingredients, excipients, and wearable device components, serving applications across air, sea, road, and specialized travel environments. Key trends include non-drowsy formulations, OTC availability, wearable anti-motion devices, personalized therapeutics, and natural remedies, presenting significant opportunities for innovation and market expansion. Regional dynamics indicate North America as the largest demand center due to advanced healthcare infrastructure and widespread pharmaceutical presence, while Asia Pacific is poised for rapid growth owing to expanding healthcare access, rising disposable incomes, and government support for pharmaceutical development. Leading companies such as GlaxoSmithKline, Pfizer, Johnson & Johnson, Prestige Consumer Healthcare, and Perrigo leverage strong R&D, global distribution, and brand presence to meet increasing consumer demand, ensuring sustained market growth and accessibility worldwide.
Our Report
https://www.sphericalinsights.com/reports/italy-seed-treatment-market
https://www.sphericalinsights.com/reports/italy-compound-feed-market
https://www.sphericalinsights.com/reports/italy-data-center-market
https://www.sphericalinsights.com/reports/italy-food-colorants-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?